Danese, A., Moffitt, TE, Pariante, CM, Ambler, A., Poulton, R., Caspi, A. ( 2008) Elevated inflammation levels in depressed adults with a history of childhood maltreatment. Arch Gen Psychiatry65: 409-415.
2.
Joyce, PR, Mulder, RT, Luty, SE, Sullivan, PF, McKenzie, JM, Abbott, RM, et al. (2002) Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline . Aust N Z J Psychiatry36: 384-391.
3.
Kuo, HK, Yen, CJ, Chang, CH, Kuo, CK, Chen, JH, Sorond, F. ( 2005) Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis . Lancet Neurol4: 371-380.
4.
Lanquillon, S., Krieg, JC, Bening-Abu-Shach, U., Vedder, H. ( 2000) Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology22: 370-379.
5.
Liukkonen, T., Silvennoinen-Kassinen, S., Jokelainen, J., Räsänen, P., Leinonen, M., Meyer-Rochow, VB, et al. (2006) The association between C-reactive protein levels and depression: Results from the northern Finland 1966 birth cohort study. Biol Psychiatry60: 825-830.
6.
Luty, SE, Carter, JD, McKenzie, JM, Rae, AM, Frampton, CM, Mulder, RT, et al. (2007) Randomised controlled trial of interpersonal psychotherapy and cognitive-behavioural therapy for depression. Br J Psychiatry190: 496-502.
7.
O’Brien, SM, Scott, LV, Dinan, TG ( 2006) Antidepressant therapy and C-reactive protein levels. Br J Psychiatry188: 449-452.
8.
Tuglu, C., Kara, SH, Caliyurt, O., Vardar, E., Abay, E. ( 2003) Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 170: 429-433.
9.
Whooley, MA, Caska, CM, Hendrickson, BE, Rourke, MA, Ho, J., Ali, S. ( 2007) Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry62: 314-320.
